Supporting cancer research with IP rights
Why are legal services an important part of Oslo Cancer Cluster? We asked Andrew Wright from Potter Clarkson to explain why they became a member.
Ny rapport: Helsenæringens verdi 2019
Rapporten gir innsikt i en næring som i 2018 omsatte for 142 milliarder kroner.
Meet our new members
Oslo Cancer Cluster proudly presents the new members who have joined our organisation during the first quarter of 2019.
The first Norwegian CAR
Made in Oslo, the first ever Norwegian CAR T cell is now a fact.
Encouraging news from BerGenBio
A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.
Giving patients a stronger voice
How can the voices of cancer patients be heard when evaluating new methods of treatment?
